Statement Of Comprehensive Income [Abstract]

ABIVAX - Filing #2810976

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Statement of comprehensive income [abstract]
Profit (loss)	— EUR	147 740 EUR	147 740 EUR	— EUR	— EUR	—	— EUR	60 740 EUR	— EUR	— EUR	60 740 EUR	60 740 EUR	— EUR	— EUR	42 452 EUR	— EUR	—	42 452 EUR
Other comprehensive income [abstract]
Other comprehensive income	— EUR	225,000 EUR	— EUR	— EUR	112,000 EUR	225,000 EUR	112,000 EUR	— EUR	— EUR	235,000 EUR	235,000 EUR	235,000 EUR	— EUR	— EUR	— EUR	169,000 EUR	169,000 EUR	169,000 EUR
Comprehensive income	— EUR	147 516 EUR	147 740 EUR	— EUR	112,000 EUR	147 516 EUR	112,000 EUR	60 740 EUR	— EUR	235,000 EUR	—	60 506 EUR	— EUR	— EUR	42 452 EUR	169,000 EUR	—	42 283 EUR